2020年3月1日至2021年1月2日美国因新冠病毒病及其他原因导致的超额死亡人数
Excess Deaths From COVID-19 and Other Causes in the US, March 1, 2020, to January 2, 2021.
作者信息
Woolf Steven H, Chapman Derek A, Sabo Roy T, Zimmerman Emily B
机构信息
Center on Society and Health, Virginia Commonwealth University School of Medicine, Richmond.
Department of Biostatistics, Virginia Commonwealth University School of Medicine, Richmond.
出版信息
JAMA. 2021 Apr 2;325(17):1786-9. doi: 10.1001/jama.2021.5199.
Abstract
This study updates an analysis of US mortality in 2020, including deaths due to COVID-19 as well as all other causes.
摘要
本研究更新了对2020年美国死亡率的分析，包括因新冠病毒病（COVID-19）以及所有其他原因导致的死亡情况。
相似文献
1
Excess Deaths From COVID-19 and Other Causes in the US, March 1, 2020, to January 2, 2021.2020年3月1日至2021年1月2日美国因新冠病毒病及其他原因导致的超额死亡人数
JAMA. 2021 Apr 2;325(17):1786-9. doi: 10.1001/jama.2021.5199.
2
Unexplained mortality during the US COVID-19 pandemic: retrospective analysis of death certificate data and critical assessment of excess death calculations.美国 COVID-19 大流行期间不明原因死亡率：死亡证明数据的回顾性分析和对超额死亡计算的批判性评估。
BMJ Open. 2021 Nov 16;11(11):e050361. doi: 10.1136/bmjopen-2021-050361.
3
COVID-19 pandemic: Coroner's database of death inquiries with clinical epidemiology and total and excess mortality analyses in the District of Kildare March to June 2020.2019冠状病毒病大流行：基尔代尔地区验尸官死亡调查数据库，包含2020年3月至6月的临床流行病学以及总死亡率和超额死亡率分析
J Forensic Leg Med. 2020 Nov;76:102072. doi: 10.1016/j.jflm.2020.102072. Epub 2020 Oct 31.
4
Excess deaths from non-COVID-19-related causes in Japan and 47 prefectures from January 2020 through May 2021 by place of death.2020年1月至2021年5月期间，日本及47个都道府县因非新冠病毒相关原因导致的超额死亡人数，按死亡地点划分。
SSM Popul Health. 2022 Sep;19:101196. doi: 10.1016/j.ssmph.2022.101196. Epub 2022 Aug 6.
5
Measuring the impact of the COVID-19 outbreak in Ecuador using preliminary estimates of excess mortality, March 17-October 22, 2020.利用 2020 年 3 月 17 日至 10 月 22 日的超额死亡率初步估计来衡量厄瓜多尔 COVID-19 疫情的影响。
Int J Infect Dis. 2021 Mar;104:297-299. doi: 10.1016/j.ijid.2020.12.045. Epub 2020 Dec 19.
6
Excess deaths in the United States during the first year of COVID-19.美国在 COVID-19 大流行的第一年的超额死亡人数。
Prev Med. 2022 Sep;162:107174. doi: 10.1016/j.ypmed.2022.107174. Epub 2022 Jul 22.
7
Excess mortality from all causes during the COVID-19 pandemic in the city of Rio de Janeiro, Brazil.巴西里约热内卢市在 COVID-19 大流行期间的全因超额死亡率。
Rev Bras Epidemiol. 2023 Feb 20;26:e230013. doi: 10.1590/1980-549720230013. eCollection 2023.
8
Assessing the Impact of the Covid-19 Pandemic on US Mortality: A County-Level Analysis.评估新冠疫情对美国死亡率的影响：县级分析。
medRxiv. 2021 Mar 22:2020.08.31.20184036. doi: 10.1101/2020.08.31.20184036.
9
COVID-19 and excess mortality in the United States: A county-level analysis.新冠疫情与美国超额死亡：县级分析
PLoS Med. 2021 May 20;18(5):e1003571. doi: 10.1371/journal.pmed.1003571. eCollection 2021 May.
10
Temporal variation of excess deaths from diabetes during the COVID-19 pandemic in the United States.美国 COVID-19 大流行期间糖尿病超额死亡的时间变化。
J Infect Public Health. 2023 Apr;16(4):483-489. doi: 10.1016/j.jiph.2023.01.018. Epub 2023 Jan 25.
引用本文的文献
1
Mortality Trends and Characteristics in a Tertiary Hospital in Southwest Saudi Arabia: A 5-Year Retrospective Study.沙特阿拉伯西南部一家三级医院的死亡率趋势及特征：一项5年回顾性研究
Medicina (Kaunas). 2025 Jul 24;61(8):1334. doi: 10.3390/medicina61081334.
2
Excess US Deaths Before, During, and After the COVID-19 Pandemic.2019冠状病毒病大流行之前、期间及之后美国的超额死亡情况。
JAMA Health Forum. 2025 May 2;6(5):e251118. doi: 10.1001/jamahealthforum.2025.1118.
3
The Impact of the COVID-19 Pandemic on Clinical Practice Education in South Korea: A Cross-Sectional Study.新冠疫情对韩国临床实践教育的影响：一项横断面研究。
Int J Environ Res Public Health. 2025 Apr 7;22(4):577. doi: 10.3390/ijerph22040577.
4
Comparison of excess deaths and laboratory-confirmed COVID-19 deaths during a large Omicron epidemic in 2022 in Hong Kong.2022年香港大规模奥密克戎疫情期间超额死亡与实验室确诊的新冠死亡病例对比
J Glob Health. 2025 Apr 11;15:04105. doi: 10.7189/jogh.15.04105.
5
Regional variations in Italy's COVID-19 death toll: a descriptive analysis of excess mortality and associated factors from 2020 to 2021.意大利新冠肺炎死亡人数的地区差异：对2020年至2021年超额死亡率及相关因素的描述性分析
Popul Health Metr. 2025 Mar 7;23(1):9. doi: 10.1186/s12963-025-00370-4.
6
Cancer Drug Targeting: Molecular Mechanism, Approaches, and Regulatory Framework.癌症药物靶向：分子机制、方法及监管框架。
Curr Pharm Des. 2025;31(22):1767-1780. doi: 10.2174/0113816128364722250126172914.
7
Multiple long-term conditions as the next transition in the global diabetes epidemic.多种长期病症成为全球糖尿病流行的下一个转变点。
Commun Med (Lond). 2025 Feb 14;5(1):42. doi: 10.1038/s43856-025-00742-9.
8
ACCREDIT: Validation of clinical score for progression of COVID-19 while hospitalized.认证：新冠病毒疾病（COVID-19）住院期间病情进展临床评分的验证
Glob Epidemiol. 2024 Dec 28;9:100181. doi: 10.1016/j.gloepi.2024.100181. eCollection 2025 Jun.
9
National Trends in Stroke Presentation, Treatments, and Outcomes During the First 2 Years of the COVID-19 Pandemic.2019年冠状病毒病大流行头两年中风的就诊情况、治疗及预后的全国趋势
Neurol Clin Pract. 2025 Apr;15(2):e200436. doi: 10.1212/CPJ.0000000000200436. Epub 2025 Jan 15.
10
Cancer statistics, 2025.2025年癌症统计数据。
CA Cancer J Clin. 2025 Jan-Feb;75(1):10-45. doi: 10.3322/caac.21871. Epub 2025 Jan 16.
本文引用的文献
1
Excess Deaths From COVID-19 and Other Causes, March-July 2020.2020 年 3 月至 7 月因 COVID-19 和其他原因导致的超额死亡人数。
JAMA. 2020 Oct 20;324(15):1562-1564. doi: 10.1001/jama.2020.19545.
Zotero 插件